News

Geron Corp. quits stem cell work

 

The Menlo Park-based biotechnology firm Geron Corp. announced recently that it was abandoning its stem cell research in favor of focusing on two cancer drugs.

The motivation appears financial, according to a statement issued by the company.

"The decision to narrow Geron's technology and therapeutic focus was made after a strategic review of the costs, value inflection timelines and clinical, manufacturing and regulatory complexities," the company said.

As a result, 66 jobs -- 38 percent of its workforce -- will be eliminated, the company said.

The news came as a blow to those hoping to benefit from stem cell therapy, a field that held promise for those paralyzed by spinal cord injuries.

Stem cells possess the ability to become any other type of cell in the body, leading Geron's scientists to explore how to grow the cells into replacement neurons that could reverse paralysis.

What is democracy worth to you?
Support local journalism.

Comments

Sorry, but further commenting on this topic has been closed.

Stay informed

Get daily headlines sent straight to your inbox.

After 39 years of cakes and pastries, Palo Alto institution Prolific Oven to close
By Elena Kadvany | 53 comments | 14,825 views

What is your climate personality?
By Sherry Listgarten | 30 comments | 1,746 views

Eat Your Values – August 15
By Laura Stec | 1 comment | 1,197 views

The Regional Housing Needs Allocation (RHNA) Process Explained
By Steve Levy | 2 comments | 1,013 views

"You Gotta Have Balls [to do counseling] . . .
By Chandrama Anderson | 0 comments | 624 views

 

Early Bird rates end Sunday!

On Friday, October 11, join us at the Palo Alto Baylands for a 5K walk, 5K run, 10K run or half marathon! All proceeds benefit local nonprofits serving children and families. Early Bird prices end Sun, Aug 18.

Register now